SCHEMBL7014590

SCHEMBL7014590

Cc1cc2c(=O)n(CC(S)CS)c(=O)[nH]c2nc1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 1/20 0.35
CYP1A2 P05177 1/20 0.33
USP2 O75604 3/20 0.31
KDM4E B2RXH2 3/20 0.31
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31
POLB P06746 2/20 0.31
RGS12 O14924 2/20 0.31
MAPT P10636 2/20 0.31
ALDH1A1 P00352 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
HPGD P15428 2/20 0.31
PKM P14618 1/20 0.31
KEAP1 Q14145 1/20 0.31
NFE2L2 Q16236 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MCOLN3 Q8TDD5 1/20 0.30
MTOR P42345 1/20 0.30
PSMD14 O00487 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7014592 1.00 FEN1 (0.35) FEN1CYP1A2USP2KDM4EMEN1
SCHEMBL7016262 0.88 USP2 (0.34) FEN1CYP1A2USP2KDM4EMEN1
SCHEMBL7016261 0.88 USP2 (0.34) FEN1CYP1A2USP2KDM4EMEN1
SCHEMBL7012468 0.79 USP2 (0.36) USP2KDM4EMEN1KMT2APOLB
SCHEMBL7012471 0.79 USP2 (0.36) USP2KDM4EMEN1KMT2APOLB
SCHEMBL7097369 0.75 USP2 (0.33) FEN1CYP1A2USP2KDM4EMEN1
SCHEMBL7016331 0.74 ADORA3 (0.37) KDM4EALDH1A1HPGD
SCHEMBL7016335 0.74 ADORA3 (0.37) KDM4EALDH1A1HPGD
SCHEMBL7022655 0.74
SCHEMBL7022651 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003089416-A1 SUBSTITUTED PYRIMIDINE-2,4(1H,3H)-DIONES FOR USE AS MATRIX METALLOPROTEINASE (MMP) INHIBITORS IBFB GMBH (DE) 2003-10-30 WO disclosed
EP-1357114-A1 Substituted pyrimidin-2,4(1H,3H)-diones as inhibitors of Matrix Metalloproteinases (MMP) IBFB GmbH Privates Institut für biomedizinische Forschung und Beratung (DE) 2003-10-29 EP disclosed